MBS847178 | Anti-PD-L1 (Atezolizumab), humanized Antibody

Anti-PD-L1 (Atezolizumab), humanized Antibody | MBS847178 | Mybiosource

Product Short Name: [PD-L1]

Product Name Synonyme: [Tecentriq; PD-L1]

Other Names: [programmed cell death 1 ligand 1 isoform b; Programmed cell death 1 ligand 1; programmed cell death 1 ligand 1; B7 homolog 1; CD274 antigen; PDCD1 ligand 1; programmed death ligand 1; CD274 molecule; B7 homolog 1]

Product Gene Name: [PD-L1]

Product Gene Name Synonyme: N/A

Other Gene Names: [CD274; CD274; B7-H; B7H1; PDL1; PD-L1; PDCD1L1; PDCD1LG1; B7H1; PDCD1L1; PDCD1LG1; PDL1; PD-L1; PDCD1 ligand 1; Programmed death ligand 1; B7-H1]

Clonality: Monoclonal

Isotype: Human IgG1

Clone: N/A

Host: Human

Reactivity: Human

Specificity: Monoclonal human IgG1 antibody against human PD-L1. Tecentriq (bio-similar) is an Fc engineered, humanized monoclonal antibody that binds to PD-L1 and blocks interaction with the PD-2 and B7.1 receptors. Tecentriq(bio-similar) is a non-glycosylated IgG1 Kappa immunoglobulin that has a calculated molecular mass of 145 kDa.

Purity: Affinity purification. IgG purified from CHO culture supernatant by protein A chromatography

Form: Colorless liquid. In phosphate buffered saline, pH7.4

Concentration: N/A

Storage Stability: Store at -20 degree C
The antibody solution should be gently mixed before use
Shelf life: ~12 months

Tested Application: Neutralization, ELISA (EIA)